Camelia S. Stancu

2.6k total citations · 1 hit paper
58 papers, 2.0k citations indexed

About

Camelia S. Stancu is a scholar working on Immunology, Surgery and Clinical Biochemistry. According to data from OpenAlex, Camelia S. Stancu has authored 58 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 16 papers in Surgery and 16 papers in Clinical Biochemistry. Recurrent topics in Camelia S. Stancu's work include Atherosclerosis and Cardiovascular Diseases (19 papers), MicroRNA in disease regulation (9 papers) and Cholesterol and Lipid Metabolism (9 papers). Camelia S. Stancu is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (19 papers), MicroRNA in disease regulation (9 papers) and Cholesterol and Lipid Metabolism (9 papers). Camelia S. Stancu collaborates with scholars based in Romania, Czechia and France. Camelia S. Stancu's co-authors include Anca V. Sima, Maya Simionescu, Laura Toma, Gabriela M. Sanda, Loredan S. Niculescu, Mariana Deleanu, N Simiónescu, M Popescu, Andreea C. Popescu and Adelina Vlad and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Camelia S. Stancu

57 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Statins: mechanism of action and effects

2001 671 citations Camelia S. Stancu, Anca V. Sima Journal of Cellular and Molecular Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Camelia S. Stancu Romania	21	649	568	418	343	324	58	2.0k
Makoto Ayaori Japan	26	547 0.8×	744 1.3×	297 0.7×	432 1.3×	219 0.7×	83	2.2k
Jean‐Louis Beaudeux France	28	883 1.4×	347 0.6×	297 0.7×	315 0.9×	297 0.9×	91	2.8k
Monica Gomaraschi Italy	28	581 0.9×	933 1.6×	359 0.9×	798 2.3×	218 0.7×	64	2.3k
Ilaria Zanotti Italy	26	883 1.4×	1.1k 2.0×	372 0.9×	475 1.4×	279 0.9×	64	2.5k
Josefa Girona Spain	31	1.1k 1.7×	541 1.0×	348 0.8×	472 1.4×	208 0.6×	108	2.5k
Diego Gómez‐Coronado Spain	27	1.0k 1.5×	996 1.8×	541 1.3×	520 1.5×	273 0.8×	80	2.8k
Josep Julve Spain	27	743 1.1×	1.0k 1.8×	368 0.9×	784 2.3×	211 0.7×	133	2.4k
Xufeng Tao China	29	1.3k 2.0×	342 0.6×	346 0.8×	171 0.5×	318 1.0×	66	2.7k
Masao Miwa Japan	32	878 1.4×	365 0.6×	166 0.4×	405 1.2×	214 0.7×	83	2.7k
Mercedes Heras Spain	27	861 1.3×	390 0.7×	205 0.5×	418 1.2×	148 0.5×	76	1.9k

Countries citing papers authored by Camelia S. Stancu

Since Specialization

Citations

This map shows the geographic impact of Camelia S. Stancu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camelia S. Stancu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camelia S. Stancu more than expected).

Fields of papers citing papers by Camelia S. Stancu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camelia S. Stancu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camelia S. Stancu. The network helps show where Camelia S. Stancu may publish in the future.

Co-authorship network of co-authors of Camelia S. Stancu

This figure shows the co-authorship network connecting the top 25 collaborators of Camelia S. Stancu. A scholar is included among the top collaborators of Camelia S. Stancu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camelia S. Stancu. Camelia S. Stancu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kardassis, Dimitris, Cécile Vindis, Camelia S. Stancu, et al.. (2024). Unravelling molecular mechanisms in atherosclerosis using cellular models and omics technologies. Vascular Pharmacology. 158. 107452–107452. 1 indexed citations

Toma, Laura, Mariana Deleanu, Gabriela M. Sanda, et al.. (2024). Bioactive Compounds Formulated in Phytosomes Administered as Complementary Therapy for Metabolic Disorders. International Journal of Molecular Sciences. 25(8). 4162–4162. 13 indexed citations

Deleanu, Mariana, Laura Toma, Gabriela M. Sanda, et al.. (2023). Formulation of Phytosomes with Extracts of Ginger Rhizomes and Rosehips with Improved Bioavailability, Antioxidant and Anti-Inflammatory Effects In Vivo. Pharmaceutics. 15(4). 1066–1066. 21 indexed citations

Niculescu, Loredan S., et al.. (2023). Elevated Levels of Circulating lncRNAs LIPCAR and MALAT1 Predict an Unfavorable Outcome in Acute Coronary Syndrome Patients. International Journal of Molecular Sciences. 24(15). 12076–12076. 8 indexed citations

Toma, Laura, Gabriela M. Sanda, Camelia S. Stancu, et al.. (2023). Oscillating Glucose Induces the Increase in Inflammatory Stress through Ninjurin-1 Up-Regulation and Stimulation of Transport Proteins in Human Endothelial Cells. Biomolecules. 13(4). 626–626. 5 indexed citations

Sima, Anca V., et al.. (2022). miR-146a-5p, miR-223-3p and miR-142-3p as Potential Predictors of Major Adverse Cardiac Events in Young Patients with Acute ST Elevation Myocardial Infarction—Added Value over Left Ventricular Myocardial Work Indices. Diagnostics. 12(8). 1946–1946. 14 indexed citations

Toma, Laura, Camelia S. Stancu, & Anca V. Sima. (2020). Endothelial Dysfunction in Diabetes Is Aggravated by Glycated Lipoproteins; Novel Molecular Therapies. Biomedicines. 9(1). 18–18. 44 indexed citations

Toma, Laura, Gabriela M. Sanda, Mina Răileanu, et al.. (2020). Ninjurin-1 upregulated by TNFα receptor 1 stimulates monocyte adhesion to human TNFα-activated endothelial cells; benefic effects of amlodipine. Life Sciences. 249. 117518–117518. 22 indexed citations

Roşca, Adrian Eugen, Camelia S. Stancu, Corin Badiu, et al.. (2019). Lipid Profile Changes Induced by Chronic Administration of Anabolic Androgenic Steroids and Taurine in Rats. Medicina. 55(9). 540–540. 13 indexed citations

10.

Niculescu, Loredan S., N Simiónescu, Elena Valeria Fuior, et al.. (2018). Inhibition of miR-486 and miR-92a decreases liver and plasma cholesterol levels by modulating lipid-related genes in hyperlipidemic hamsters. Molecular Biology Reports. 45(4). 497–509. 23 indexed citations

11.

Sanda, Gabriela M., Mariana Deleanu, Laura Toma, et al.. (2016). Oxidized LDL‐Exposed Human Macrophages Display Increased MMP‐9 Expression and Secretion Mediated by Endoplasmic Reticulum Stress. Journal of Cellular Biochemistry. 118(4). 661–669. 19 indexed citations

12.

Toma, Laura, et al.. (2012). COMBINED EFFECT OF INFLAMMATORY C-REACTIVE PROTEIN AND HYPERGLYCEMIA ON ENDOTHELIAL CELL DYSFUNCTION. 2 indexed citations

13.

Toma, Laura, Camelia S. Stancu, Gabriela M. Sanda, & Anca V. Sima. (2011). Anti-oxidant and anti-inflammatory mechanisms of amlodipine action to improve endothelial cell dysfunction induced by irreversibly glycated LDL. Biochemical and Biophysical Research Communications. 411(1). 202–207. 30 indexed citations

14.

Sima, Anca V., et al.. (2009). Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress. Journal of Cellular and Molecular Medicine. 14(12). 2790–2802. 56 indexed citations

15.

Sima, Anca V., et al.. (2007). Apolipoprotein E polymorphism – a risk factor for metabolic syndrome. Clinical Chemistry and Laboratory Medicine (CCLM). 45(9). 1149–53. 50 indexed citations

16.

Sima, Anca V. & Camelia S. Stancu. (2002). Modified lipoproteins accumulate in human coronary atheroma. Journal of Cellular and Molecular Medicine. 6(1). 110–111. 9 indexed citations

17.

Stancu, Camelia S. & Anca V. Sima. (2001). Statins: mechanism of action and effects. Journal of Cellular and Molecular Medicine. 5(4). 378–387. 671 indexed citations breakdown →

18.

Niculescu, Loredan S., et al.. (2001). The total peroxyl radical trapping potential in serum ‐ an assay to define the stage of atherosclerosis. Journal of Cellular and Molecular Medicine. 5(3). 285–294. 18 indexed citations

19.

Sima, Anca V., et al.. (1998). Immunodetection of modified lipoproteins in plasma and arterial walls of patients with coronary heart disease.. PubMed. 35(1-4). 29–38. 2 indexed citations

20.

Sima, Anca V., Doina Popov, Olga Starodub, et al.. (1997). Pathobiology of the heart in experimental diabetes: immunolocalization of lipoproteins, immunoglobulin G, and advanced glycation endproducts proteins in diabetic and/or hyperlipidemic hamster.. PubMed. 77(1). 3–18. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact